JP2001519815A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001519815A5 JP2001519815A5 JP1998543154A JP54315498A JP2001519815A5 JP 2001519815 A5 JP2001519815 A5 JP 2001519815A5 JP 1998543154 A JP1998543154 A JP 1998543154A JP 54315498 A JP54315498 A JP 54315498A JP 2001519815 A5 JP2001519815 A5 JP 2001519815A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4189097P | 1997-04-10 | 1997-04-10 | |
| US60/041,890 | 1997-04-10 | ||
| PCT/US1998/007234 WO1998044940A1 (en) | 1997-04-10 | 1998-04-10 | Use of lactoferin in the treatment of allergen induced disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001519815A JP2001519815A (ja) | 2001-10-23 |
| JP2001519815A5 true JP2001519815A5 (enExample) | 2005-11-24 |
Family
ID=21918897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54315498A Ceased JP2001519815A (ja) | 1997-04-10 | 1998-04-10 | アレルゲン誘発性障害の治療におけるラクトフェリンの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030190303A1 (enExample) |
| EP (1) | EP0979099B1 (enExample) |
| JP (1) | JP2001519815A (enExample) |
| CN (1) | CN1262625A (enExample) |
| AT (1) | ATE297755T1 (enExample) |
| AU (1) | AU747385C (enExample) |
| CA (1) | CA2285960A1 (enExample) |
| DE (1) | DE69830582T2 (enExample) |
| ES (1) | ES2245028T3 (enExample) |
| IL (1) | IL132293A0 (enExample) |
| NZ (1) | NZ500712A (enExample) |
| WO (1) | WO1998044940A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL336626A1 (en) * | 1997-05-03 | 2000-07-03 | Regents Board Of | Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| AU782539B2 (en) * | 2000-01-14 | 2005-08-04 | Meiji Dairies Corporation | Antigen-specific IgE antibody production inhibitors |
| RU2165769C1 (ru) * | 2000-07-13 | 2001-04-27 | Якубовская Раиса Ивановна | Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения |
| MY143582A (en) | 2001-06-26 | 2011-05-31 | Amgent Fremont Inc | Antibodies to opgl |
| AU2002359949A1 (en) * | 2001-12-28 | 2003-07-24 | Nrl Pharma, Inc. | Compositions for improving lipid metabolism |
| JP3806427B2 (ja) * | 2002-01-21 | 2006-08-09 | 株式会社Ｎｒｌファーマ | 新規鎮痛剤 |
| CN100467060C (zh) * | 2002-05-10 | 2009-03-11 | 阿根尼克斯有限公司 | 通过瘤内施用乳铁蛋白治疗恶性肿瘤疾病的用途 |
| AU2003233583A1 (en) * | 2002-05-24 | 2003-12-12 | Agennix Incorporated | Oral lactoferrin in the treatment of respiratory disorders |
| ME00204B (me) | 2002-09-06 | 2011-02-10 | Medarex Llc | Terapijsko, humano, monoklonsko anti-il-1r1antitijelo |
| JP4516844B2 (ja) * | 2002-09-16 | 2010-08-04 | エイジェニックス インコーポレイテッド | 創傷の処置におけるラクトフェリン |
| AU2003298906A1 (en) * | 2002-12-06 | 2004-06-30 | Agennix Incorporated | Oral lactoferrin in the treatment of sepsis |
| US7592306B2 (en) * | 2002-12-10 | 2009-09-22 | Agennix, Inc. | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US8105615B2 (en) * | 2003-06-06 | 2012-01-31 | Agennix Incorporated | Lactoferrin as an adjuvant in cancer vaccines |
| WO2005018542A2 (en) * | 2003-07-10 | 2005-03-03 | Agennix Incorporated | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
| JP2008501772A (ja) * | 2004-06-11 | 2008-01-24 | シンジェンタ リミテッド | 炎症性皮膚状態を寛解するための方法 |
| US7183381B2 (en) | 2004-10-26 | 2007-02-27 | Agennix, Inc. | Composition of lactoferrin related peptides and uses thereof |
| WO2006098625A1 (en) * | 2005-03-15 | 2006-09-21 | Campina Nederland Holding B.V. | Dermatologic use of milk proteins |
| US8178486B2 (en) * | 2005-07-21 | 2012-05-15 | Animal Technology Institute Taiwan | Method for promoting hair growth |
| US20090270309A1 (en) * | 2005-10-14 | 2009-10-29 | Jillian Cornish | Use of lactoferrin fragments and hydrolysates |
| US20090130191A1 (en) * | 2005-10-27 | 2009-05-21 | Sunstar Inc. | Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin |
| AU2011242415B2 (en) * | 2010-04-23 | 2017-02-16 | Probiotec Limited | Eczema treatment |
| CN102370964B (zh) * | 2010-08-16 | 2015-12-09 | 李兴德 | 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用 |
| IT201800002457A1 (it) * | 2018-02-07 | 2019-08-07 | Neilos S R L | Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie |
| US12403181B2 (en) | 2018-08-13 | 2025-09-02 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
| EP4072322B1 (en) * | 2019-12-11 | 2025-01-29 | N.V. Nutricia | Nutritional composition for improving immune fitness |
| US20250283174A1 (en) | 2022-05-16 | 2025-09-11 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stem cells induced by chronic inflammation |
| CN115737787B (zh) * | 2022-12-15 | 2024-04-19 | 四川大学 | 乳铁蛋白联合胆碱在制备预防和/或治疗阿尔兹海默症的药物中的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2641696B2 (fr) * | 1986-04-11 | 1991-03-08 | Sederma Sa | Utilisation d'un melange renfermant de la lactoferrine dans des preparations cosmetiques anti-radicaux libres |
| FR2596986B1 (fr) * | 1986-04-11 | 1988-09-23 | Sederma Sa | Utilisation de la lactoferrine dans des preparations cosmetiques, antiradicaux libres |
| FR2685202B1 (fr) * | 1991-12-24 | 1995-03-24 | Sederma Sa | Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee. |
| JP3184923B2 (ja) * | 1992-01-08 | 2001-07-09 | ビオ セレ ラボラトワール エス ア | 抗リウマチ剤 |
| JPH05279266A (ja) * | 1992-04-02 | 1993-10-26 | Imuno Japan:Kk | 歯周病の治療・予防用医薬組成物 |
| JP3163171B2 (ja) * | 1992-07-15 | 2001-05-08 | 森永乳業株式会社 | ＩｇＡ産生促進剤 |
| JP3746081B2 (ja) * | 1994-02-24 | 2006-02-15 | 森永乳業株式会社 | 動物皮膚病治療剤 |
| JPH0859450A (ja) * | 1994-08-18 | 1996-03-05 | Kose Corp | 皮膚外用剤 |
| JP2832517B2 (ja) * | 1994-12-09 | 1998-12-09 | 雪印乳業株式会社 | 大腸菌付着阻止剤 |
| JP3911642B2 (ja) * | 1995-06-06 | 2007-05-09 | 株式会社加美乃素本舗 | 皮膚外用剤 |
| JP3888707B2 (ja) * | 1996-01-22 | 2007-03-07 | 森永乳業株式会社 | 血管新生病治療剤 |
| US6111081A (en) * | 1996-05-31 | 2000-08-29 | Baylor College Of Medicine | Lactoferrin variants and uses thereof |
-
1998
- 1998-04-10 AT AT98915471T patent/ATE297755T1/de not_active IP Right Cessation
- 1998-04-10 CN CN98805584A patent/CN1262625A/zh active Pending
- 1998-04-10 ES ES98915471T patent/ES2245028T3/es not_active Expired - Lifetime
- 1998-04-10 AU AU69647/98A patent/AU747385C/en not_active Ceased
- 1998-04-10 NZ NZ500712A patent/NZ500712A/xx not_active IP Right Cessation
- 1998-04-10 EP EP98915471A patent/EP0979099B1/en not_active Expired - Lifetime
- 1998-04-10 US US09/058,589 patent/US20030190303A1/en not_active Abandoned
- 1998-04-10 CA CA002285960A patent/CA2285960A1/en not_active Abandoned
- 1998-04-10 JP JP54315498A patent/JP2001519815A/ja not_active Ceased
- 1998-04-10 WO PCT/US1998/007234 patent/WO1998044940A1/en not_active Ceased
- 1998-04-10 DE DE69830582T patent/DE69830582T2/de not_active Expired - Lifetime
- 1998-04-10 IL IL13229398A patent/IL132293A0/xx not_active IP Right Cessation